Figure 1.

Number of allogeneic stem cell transplant (SCT) recipients who received intermittent administration of high-dose micafungin between 2009 and 2014, presented as absolute numbers and proportion of allogeneic SCT recipients performed per year. P values between 2013 and 2012, 2011, 2010, and 2009 were .0075, .0005, .0001, and .0001, respectively. Fisher exact test was used to assess the difference between 2013 and prior years. Analyses were not performed for 2014 due to data collection reflecting only the first part of the year.